Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

Eltrombopag is a thrombopoietin agonist and has been used in aplastic anemia and post-transplantation thrombocytopenia. The c-MPL receptor is present on hematopoietic stem cells. There are no reports of eltrombopag utilization for improving poor graft function in the post-transplant setting. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales: Master, Samip, Dwary, Ashish, Mansour, Richard, Mills, Glenn M., Koshy, Nebu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903126/
https://www.ncbi.nlm.nih.gov/pubmed/29681820
http://dx.doi.org/10.1159/000487229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903126/
https://www.ncbi.nlm.nih.gov/pubmed/29681820
http://dx.doi.org/10.1159/000487229

Ejemplares similares